Greenland Mines Ltd

Greenland Mines Ltd

GRMLW
Greenland Mines LtdUS flagNASDAQ Global Market
0.18
USD
+0.00
- -
13.04MMarket Cap
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChatGPT
CEO
Joseph A. Sinkule
Full Time Employees
5
Sector
Basic Materials
Industry
Other Precious Metals
Address
13576 Walnut Street Charlotte NE United States of America 68144
IPO Date
Apr 29, 2022
Business
Greenland Mines Ltd is a natural resources company focused on the exploration and development of the Skaergaard Project in Southeast Greenland, one of the world’s largest undeveloped gold, palladium, and platinum deposits, with a total in-situ resource value estimated at approximately $68 billion based on February 2026 prices; the company also operates a division focused on cell and gene therapies. Headquarters are in Paris, Île-de-France, France, with a broader geographic footprint encompassing Greenland and associated international operations. Founded in 2026, Greenland Mines Ltd holds an 80% interest in the Skaergaard Project, with an option to acquire the remaining 20%, and pursues ongoing drilling, resource delineation, and development programs to advance the project toward potential future production; it also maintains corporate activities and investor communications through its public listings and investor relations channels. Main products and services include mineral exploration and development services for precious metals (gold, palladium, platinum) and associated metals, project management and technical advisory services related to mining operations, and the development and commercialization efforts in its cell and gene therapy division, including KLTO-202 for amyotrophic lateral sclerosis. The company’s strategy emphasizes expanding resource potential, advancing feasibility and environmental studies, securing strategic partnerships, and pursuing potential acquisitions or joint ventures to enhance value creation in Greenland’s mineral endowment while leveraging its governance and financing capabilities to support project execution. Greenland Mines Ltd operates within the mining, precious metals, and biotechnology spaces, serving investors, strategic partners, and potentially downstream users of metals arising from the Skaergaard deposit and related therapeutic ventures.